Scott Daniel Cormack, President and CEO at ONCOGENEX PHARMACEUTICALS, INC. (OGXI), sold 4,856 shares at $1.03 ($5K) on 2016-06-13, disclosed to the SEC on 2016-06-15.
Open-market sale of $5k OGXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OGXI | SELL | 2015-05-21 | $14K | — | Filing → |
| OGXI | SELL | 2014-08-14 | $58K | — | Filing → |
| OGXI | SELL | 2014-03-18 | $57K | — | Filing → |